Gallbladder cancer

Bas Groot Koerkamp; William R. Jarnagin

doi:10.1007/978-1-4939-1423-4_11

Gallbladder cancer

Bas Groot Koerkamp
, William R. Jarnagin^*

^*Corresponding author for this work

Memorial Sloan-Kettering Cancer Center

Research output: Chapter/Conference proceeding › Chapter › Academic

1 Citation (Scopus)

Abstract

Gallbladder cancer (GBC) is the most common biliary cancer with an annual incidence of about 6,000 patients in the USA. These patients may present to the surgical oncologist with abnormal findings on imaging such as a gallbladder polyp or a gallbladder and/or liver mass suspicious for GBC. Other common presentations are an incidental GBC suspected during cholecystectomy for cholelithiasis or found at pathologic review after cholecystectomy. Diagnosis and treatment are explained for the different presentations. A cholecystectomy with en bloc liver resection of segments 4b and 5 with lymph node dissection of the hepatoduodenal ligament is recommended for most medically fit patients with resectable GBC. After a potentially curative resection, the median survival and the 5-year survival rate for patients in the SEER database were 16 months and 21 %, respectively.

Original language	English
Title of host publication	Surgical Oncology a Practical and Comprehensive Approach
Publisher	Springer New York
Pages	235-255
Number of pages	21
ISBN (Electronic)	9781493914234
ISBN (Print)	9781493914227
DOIs	https://doi.org/10.1007/978-1-4939-1423-4_11
Publication status	Published - 1 Jan 2015
Externally published	Yes

Bibliographical note

Publisher Copyright:
© Springer Science+Business Media New York 2015.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/978-1-4939-1423-4_11

Cite this

@inbook{5361e6c2179042eea1d3472421718bbe,

title = "Gallbladder cancer",

abstract = "Gallbladder cancer (GBC) is the most common biliary cancer with an annual incidence of about 6,000 patients in the USA. These patients may present to the surgical oncologist with abnormal findings on imaging such as a gallbladder polyp or a gallbladder and/or liver mass suspicious for GBC. Other common presentations are an incidental GBC suspected during cholecystectomy for cholelithiasis or found at pathologic review after cholecystectomy. Diagnosis and treatment are explained for the different presentations. A cholecystectomy with en bloc liver resection of segments 4b and 5 with lymph node dissection of the hepatoduodenal ligament is recommended for most medically fit patients with resectable GBC. After a potentially curative resection, the median survival and the 5-year survival rate for patients in the SEER database were 16 months and 21 \%, respectively.",

author = "Koerkamp, \{Bas Groot\} and Jarnagin, \{William R.\}",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-1-4939-1423-4\_11",

language = "English",

isbn = "9781493914227",

pages = "235--255",

booktitle = "Surgical Oncology a Practical and Comprehensive Approach",

publisher = "Springer New York",

address = "United States",

}

TY - CHAP

T1 - Gallbladder cancer

AU - Koerkamp, Bas Groot

AU - Jarnagin, William R.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Gallbladder cancer (GBC) is the most common biliary cancer with an annual incidence of about 6,000 patients in the USA. These patients may present to the surgical oncologist with abnormal findings on imaging such as a gallbladder polyp or a gallbladder and/or liver mass suspicious for GBC. Other common presentations are an incidental GBC suspected during cholecystectomy for cholelithiasis or found at pathologic review after cholecystectomy. Diagnosis and treatment are explained for the different presentations. A cholecystectomy with en bloc liver resection of segments 4b and 5 with lymph node dissection of the hepatoduodenal ligament is recommended for most medically fit patients with resectable GBC. After a potentially curative resection, the median survival and the 5-year survival rate for patients in the SEER database were 16 months and 21 %, respectively.

AB - Gallbladder cancer (GBC) is the most common biliary cancer with an annual incidence of about 6,000 patients in the USA. These patients may present to the surgical oncologist with abnormal findings on imaging such as a gallbladder polyp or a gallbladder and/or liver mass suspicious for GBC. Other common presentations are an incidental GBC suspected during cholecystectomy for cholelithiasis or found at pathologic review after cholecystectomy. Diagnosis and treatment are explained for the different presentations. A cholecystectomy with en bloc liver resection of segments 4b and 5 with lymph node dissection of the hepatoduodenal ligament is recommended for most medically fit patients with resectable GBC. After a potentially curative resection, the median survival and the 5-year survival rate for patients in the SEER database were 16 months and 21 %, respectively.

UR - https://www.scopus.com/pages/publications/84944043426

U2 - 10.1007/978-1-4939-1423-4_11

DO - 10.1007/978-1-4939-1423-4_11

M3 - Chapter

AN - SCOPUS:84944043426

SN - 9781493914227

SP - 235

EP - 255

BT - Surgical Oncology a Practical and Comprehensive Approach

PB - Springer New York

ER -

Gallbladder cancer

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this